Research Article
Cost-Effectiveness Analysis for the Treatment of Hyperphosphatemia in Predialysis Patients: Calcium-Based versus Noncalcium-Based Phosphate Binders
Table 1
INDEPENDENT-CKD trial patient characteristics.
| | Patient characteristics | Sevelamer | CaCO3 |
| | Subjects (N) | 107 | 105 | | Mean age (years) | 57.4 | 58.5 | | Males (%) | 61 | 61 | | CKD disease stage | Stage 3–4 | Stage 3–4 | | Diabetes (%) | 27 | 29 | | Hypertension (%) | 72.9 | 76.1 | | Baseline creatinine clearance (CCr) (ml/min) | 31.7 | 32.7 | | Baseline phosphorus (mg/dl) | 4.82 | 4.87 | | Baseline calcium (mg/dl) | 9.0 | 8.8 | | Baseline parathyroid hormone (PTH) (pg/ml) | 200 | 188 |
|
|
